
    
      The main objective is to estimate the systemic exposure of OMS201 in retrograde ureteroscopic
      treatment of upper urinary tract stones. Safety will be assessed by vital signs, laboratory
      values and adverse events. Exploratory efficacy measures will assess the effect of OMS201 on
      postoperative pain, duration of surgery and ease of placement of a ureteral access sheath.
    
  